Peptide–and protein–nanoparticle conjugates have emerged as powerful tools for
biomedical applications, enabling the treatment, diagnosis, and prevention of disease. In …

The development of drug delivery systems using nanoparticles as carriers for small and
large therapeutic molecules remains a rapidly growing area of research. The advantages of …

Nature employs a variety of tactics to precisely time and execute the processes and
mechanics of life, relying on sequential sense and response cascades to transduce …

Aqueous solutions that undergo sol-to-gel transition as the temperature increases have
been extensively studied during the last decade. The material can be designed by …

Elastin-like polypeptides (ELPs) are biopolymers inspired by human elastin. Their lower
critical solution temperature phase transition behavior and biocompatibility make them …

The use of recombinant elastin-like materials, or elastin-like recombinamers (ELRs), in drug-
delivery applications is reviewed in this work. Although ELRs were initially used in similar …

The application of block copolymer micelles (BCMs) in oncology has benefitted from
advances in polymer chemistry, drug formulation and delivery as well as in vitro and in vivo …

Biomaterials produced by nature have been honed through billions of years, evolving
exquisitely precise structure–function relationships that scientists strive to emulate …

New and improved nanomaterials are constantly being developed for biomedical purposes.
Nanomaterials based on elastin-like polypeptides (ELPs) have increasingly shown potential …

Well‐defined tunable nanostructures formed through the hierarchical self‐assembly of
peptide building blocks have drawn significant attention due to their potential applications in …